Alkermes (ALKS) PT Raised to $58 at BofA/Merrill Lynch
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $24.65 +1.61%
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
BofA/Merrill Lynch analyst Jason Gerberry raised the price target on Alkermes (NASDAQ: ALKS) to $58.00 (from $55.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
- Sherwin-Williams (SHW) PT Lowered to $286 at BofA Securities, 'risk to valuation'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
